Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 164 entries
Sorted by: Best Match Show Resources per page
Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial.

Journal of reproduction & infertility

Akbarzadeh M, Zeinalzadeh S, Zolghadri J, Mohagheghzadeh A, Faridi P, Sayadi M.
PMID: 25473627
J Reprod Infertil. 2014 Oct;15(4):190-8.

BACKGROUND: Orgasmic disorder can create a feeling of deprivation and failure and provide mental problems, incompatibility and marital discord. This study aimed to compare the effects of Elaeagnus angustifolia flower extract and sildenafil citrate on female orgasmic disorder in...

Cite
Akbarzadeh M, Zeinalzadeh S, Zolghadri J, et al. Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial. J Reprod Infertil. 2014;15(4):190-8
Akbarzadeh, M., Zeinalzadeh, S., Zolghadri, J., Mohagheghzadeh, A., Faridi, P., & Sayadi, M. (2014). Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial. Journal of reproduction & infertility, 15(4), 190-8.
Akbarzadeh, Marzieh, et al. "Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial." Journal of reproduction & infertility vol. 15,4 (2014): 190-8.
Akbarzadeh M, Zeinalzadeh S, Zolghadri J, Mohagheghzadeh A, Faridi P, Sayadi M. Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial. J Reprod Infertil. 2014 Oct;15(4):190-8. PMID: 25473627; PMCID: PMC4227976.
Copy Download .nbib Format: NLM
Sildenafil citrate in fetal growth restriction.

Journal of reproduction & infertility

Panda S, Das A, Md Nowroz H.
PMID: 25202677
J Reprod Infertil. 2014 Jul;15(3):168-9.

BACKGROUND: Pregnancies with early onset fetal growth restriction have poor perinatal outcome. Sildenafil citrate (PDE -5 inhibitor) as a vasodilator increases utero-placental blood flow and potentiates fetal growth.CASE PRESENTATION: In this study, a case was examined and Sildenafil was...

Cite
Panda S, Das A, Md Nowroz H. Sildenafil citrate in fetal growth restriction. J Reprod Infertil. 2014;15(3):168-9
Panda, S., Das, A., & Md Nowroz, H. (2014). Sildenafil citrate in fetal growth restriction. Journal of reproduction & infertility, 15(3), 168-9.
Panda, Subrat, et al. "Sildenafil citrate in fetal growth restriction." Journal of reproduction & infertility vol. 15,3 (2014): 168-9.
Panda S, Das A, Md Nowroz H. Sildenafil citrate in fetal growth restriction. J Reprod Infertil. 2014 Jul;15(3):168-9. PMID: 25202677; PMCID: PMC4138426.
Copy Download .nbib Format: NLM
Large Atrial Septal Defect Closure in a Patient with Severe Pulmonary Arterial Hypertension.

The Korean journal of thoracic and cardiovascular surgery

Supomo S, Hartopo AB, Anggrahini DW, Darmawan H, Dinarti LK.
PMID: 29124030
Korean J Thorac Cardiovasc Surg. 2017 Oct;50(5):378-381. doi: 10.5090/kjtcs.2017.50.5.378. Epub 2017 Oct 05.

Patients with an atrial septal defect (ASD) and severe pulmonary arterial hypertension (PAH) are considered ineligible for defect closure surgery because of the risk of right ventricular decompensation and death after the operation. We report the case of a...

Cite
Supomo S, Hartopo AB, Anggrahini DW, et al. Large Atrial Septal Defect Closure in a Patient with Severe Pulmonary Arterial Hypertension. Korean J Thorac Cardiovasc Surg. 2017;50(5):378-381doi: 10.5090/kjtcs.2017.50.5.378.
Supomo, S., Hartopo, A. B., Anggrahini, D. W., Darmawan, H., & Dinarti, L. K. (2017). Large Atrial Septal Defect Closure in a Patient with Severe Pulmonary Arterial Hypertension. The Korean journal of thoracic and cardiovascular surgery, 50(5), 378-381. https://doi.org/10.5090/kjtcs.2017.50.5.378
Supomo, Supomo, et al. "Large Atrial Septal Defect Closure in a Patient with Severe Pulmonary Arterial Hypertension." The Korean journal of thoracic and cardiovascular surgery vol. 50,5 (2017): 378-381. doi: https://doi.org/10.5090/kjtcs.2017.50.5.378
Supomo S, Hartopo AB, Anggrahini DW, Darmawan H, Dinarti LK. Large Atrial Septal Defect Closure in a Patient with Severe Pulmonary Arterial Hypertension. Korean J Thorac Cardiovasc Surg. 2017 Oct;50(5):378-381. doi: 10.5090/kjtcs.2017.50.5.378. Epub 2017 Oct 05. PMID: 29124030; PMCID: PMC5628966.
Copy Download .nbib Format: NLM
Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature.

The world journal of men's health

Park HJ, Moon KH, Lee SW, Lee WK, Kam SC, Lee JH, Park NC.
PMID: 24872948
World J Mens Health. 2014 Apr;32(1):18-27. doi: 10.5534/wjmh.2014.32.1.18. Epub 2014 Apr 25.

Phosphodiesterase type 5 (PDE5) inhibitors are the most commonly used treatment for erectile dysfunction (ED). Since the launch of sildenafil, several drugs-including mirodenafil, sildenafil citrate (sildenafil), tadalafil, vardenafil HCL (vardenafil), udenafil, and avanafil-have become available. Mirodenafil is a newly...

Cite
Park HJ, Moon KH, Lee SW, et al. Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature. World J Mens Health. 2014;32(1):18-27doi: 10.5534/wjmh.2014.32.1.18.
Park, H. J., Moon, K. H., Lee, S. W., Lee, W. K., Kam, S. C., Lee, J. H., & Park, N. C. (2014). Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature. The world journal of men's health, 32(1), 18-27. https://doi.org/10.5534/wjmh.2014.32.1.18
Park, Hyun Jun, et al. "Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature." The world journal of men's health vol. 32,1 (2014): 18-27. doi: https://doi.org/10.5534/wjmh.2014.32.1.18
Park HJ, Moon KH, Lee SW, Lee WK, Kam SC, Lee JH, Park NC. Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature. World J Mens Health. 2014 Apr;32(1):18-27. doi: 10.5534/wjmh.2014.32.1.18. Epub 2014 Apr 25. PMID: 24872948; PMCID: PMC4026230.
Copy Download .nbib Format: NLM
Sildenafil citrate and uteroplacental perfusion in fetal growth restriction.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Dastjerdi MV, Hosseini S, Bayani L.
PMID: 23798922
J Res Med Sci. 2012 Jul;17(7):632-6.

BACKGROUND: To determine whether the phosphodiesterase type 5 inhibitor, Sildenafil citrate, affects uteroplacental perfusion.MATERIALS AND METHODS: Based on a randomized double-blinded and placebo-controlled trial, forty one pregnant women with documented intrauterine growth retardation at 24-37 weeks of gestation were...

Cite
Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci. 2012;17(7):632-6
Dastjerdi, M. V., Hosseini, S., & Bayani, L. (2012). Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 17(7), 632-6.
Dastjerdi, Marzieh Vahid, et al. "Sildenafil citrate and uteroplacental perfusion in fetal growth restriction." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 17,7 (2012): 632-6.
Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci. 2012 Jul;17(7):632-6. PMID: 23798922; PMCID: PMC3685778.
Copy Download .nbib Format: NLM
Comparative evaluation of the aphrodisiac efficacy of sildenafil and Carpolobia lutea root extract in male rabbits.

Journal of intercultural ethnopharmacology

Dare A, Salami SA, Kunle-Alabi OT, Akindele OO, Raji Y.
PMID: 26649235
J Intercult Ethnopharmacol. 2015 Oct-Dec;4(4):302-7. doi: 10.5455/jice.20151101092942. Epub 2015 Nov 05.

AIMS: In spite of the folkloric use of the root of Carpolobia lutea as a sexual stimulant in man, there has been limited scientific proof of its efficacy. This study compares the efficacy of methanol extract of C. lutea...

Cite
Dare A, Salami SA, Kunle-Alabi OT, et al. Comparative evaluation of the aphrodisiac efficacy of sildenafil and Carpolobia lutea root extract in male rabbits. J Intercult Ethnopharmacol. 2015;4(4):302-7doi: 10.5455/jice.20151101092942.
Dare, A., Salami, S. A., Kunle-Alabi, O. T., Akindele, O. O., & Raji, Y. (2015). Comparative evaluation of the aphrodisiac efficacy of sildenafil and Carpolobia lutea root extract in male rabbits. Journal of intercultural ethnopharmacology, 4(4), 302-7. https://doi.org/10.5455/jice.20151101092942
Dare, Ayobami, et al. "Comparative evaluation of the aphrodisiac efficacy of sildenafil and Carpolobia lutea root extract in male rabbits." Journal of intercultural ethnopharmacology vol. 4,4 (2015): 302-7. doi: https://doi.org/10.5455/jice.20151101092942
Dare A, Salami SA, Kunle-Alabi OT, Akindele OO, Raji Y. Comparative evaluation of the aphrodisiac efficacy of sildenafil and Carpolobia lutea root extract in male rabbits. J Intercult Ethnopharmacol. 2015 Oct-Dec;4(4):302-7. doi: 10.5455/jice.20151101092942. Epub 2015 Nov 05. PMID: 26649235; PMCID: PMC4665025.
Copy Download .nbib Format: NLM
Priapism associated with novel psychoactive substance abuse.

Central European journal of urology

Jones P, Rai BP, Doig S, Ahammed N.
PMID: 26855798
Cent European J Urol. 2015;68(4):447-9. doi: 10.5173/ceju.2015.676. Epub 2015 Nov 04.

Priapism is a time-dependent emergency, which can lead to marked adverse effects on erectile function. We present the case of a patient with bipolar disorder who consumed a novel psychoactive substance, as well as an illegal substitute for sildenafil...

Cite
Jones P, Rai BP, Doig S, et al. Priapism associated with novel psychoactive substance abuse. Cent European J Urol. 2015;68(4):447-9doi: 10.5173/ceju.2015.676.
Jones, P., Rai, B. P., Doig, S., & Ahammed, N. (2015). Priapism associated with novel psychoactive substance abuse. Central European journal of urology, 68(4), 447-9. https://doi.org/10.5173/ceju.2015.676
Jones, Patrick, et al. "Priapism associated with novel psychoactive substance abuse." Central European journal of urology vol. 68,4 (2015): 447-9. doi: https://doi.org/10.5173/ceju.2015.676
Jones P, Rai BP, Doig S, Ahammed N. Priapism associated with novel psychoactive substance abuse. Cent European J Urol. 2015;68(4):447-9. doi: 10.5173/ceju.2015.676. Epub 2015 Nov 04. PMID: 26855798; PMCID: PMC4742444.
Copy Download .nbib Format: NLM
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial.

Arab journal of urology

Fawzi A, Kamel M, Salem E, Desoky E, Omran M, Elgalaly H, Sakr A, Maarouf A, Khalil S.
PMID: 28275519
Arab J Urol. 2016 Dec 29;15(1):53-59. doi: 10.1016/j.aju.2016.11.001. eCollection 2017 Mar.

OBJECTIVE: To assess the additive effect of sildenafil citrate to tamsulosin in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) in men with or without erectile dysfunction (ED).PATIENTS AND METHODS: In all, 150 men...

Cite
Fawzi A, Kamel M, Salem E, et al. Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial. Arab J Urol. 2016;15(1):53-59doi: 10.1016/j.aju.2016.11.001.
Fawzi, A., Kamel, M., Salem, E., Desoky, E., Omran, M., Elgalaly, H., Sakr, A., Maarouf, A., & Khalil, S. (2017). Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial. Arab journal of urology, 15(1), 53-59. https://doi.org/10.1016/j.aju.2016.11.001
Fawzi, Amr, et al. "Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial." Arab journal of urology vol. 15,1 (2017): 53-59. doi: https://doi.org/10.1016/j.aju.2016.11.001
Fawzi A, Kamel M, Salem E, Desoky E, Omran M, Elgalaly H, Sakr A, Maarouf A, Khalil S. Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial. Arab J Urol. 2016 Dec 29;15(1):53-59. doi: 10.1016/j.aju.2016.11.001. eCollection 2017 Mar. PMID: 28275519; PMCID: PMC5329701.
Copy Download .nbib Format: NLM
Primary Combined Latissimus Dorsi and Serratus Anterior Flap Repair of Right-Sided Congenital Diaphragmatic Agenesis in a Neonate.

Sultan Qaboos University medical journal

Samuel M, Parapurath R.
PMID: 26909223
Sultan Qaboos Univ Med J. 2016 Feb;16(1):e96-e100. doi: 10.18295/squmj.2016.16.01.018. Epub 2016 Feb 02.

Large diaphragmatic defects can be repaired with latissimus dorsi and serratus anterior muscle flaps. We report the first successful primary repair of complete congenital diaphragmatic agenesis using a combination of autologous living bio-tissue and synthetic mesh in a neonate...

Cite
Samuel M, Parapurath R. Primary Combined Latissimus Dorsi and Serratus Anterior Flap Repair of Right-Sided Congenital Diaphragmatic Agenesis in a Neonate. Sultan Qaboos Univ Med J. 2016;16(1):e96-e100doi: 10.18295/squmj.2016.16.01.018.
Samuel, M., & Parapurath, R. (2016). Primary Combined Latissimus Dorsi and Serratus Anterior Flap Repair of Right-Sided Congenital Diaphragmatic Agenesis in a Neonate. Sultan Qaboos University medical journal, 16(1), e96-e100. https://doi.org/10.18295/squmj.2016.16.01.018
Samuel, Madan, and Parapurath, Rajiv. "Primary Combined Latissimus Dorsi and Serratus Anterior Flap Repair of Right-Sided Congenital Diaphragmatic Agenesis in a Neonate." Sultan Qaboos University medical journal vol. 16,1 (2016): e96-e100. doi: https://doi.org/10.18295/squmj.2016.16.01.018
Samuel M, Parapurath R. Primary Combined Latissimus Dorsi and Serratus Anterior Flap Repair of Right-Sided Congenital Diaphragmatic Agenesis in a Neonate. Sultan Qaboos Univ Med J. 2016 Feb;16(1):e96-e100. doi: 10.18295/squmj.2016.16.01.018. Epub 2016 Feb 02. PMID: 26909223; PMCID: PMC4746053.
Copy Download .nbib Format: NLM
Determination of sildenafil citrate (viagra) and its metabolite (UK-103,320) by square-wave and adsorptive stripping square-wave voltammetry. Total determination in biological samples.

Talanta

Rodríguez J, Berzas JJ, Castañeda G, Rodríguez N.
PMID: 18969313
Talanta. 2004 Feb 06;62(2):427-32. doi: 10.1016/j.talanta.2003.07.017.

The voltammetric behaviour of Sildenafil citrate (SC) and its main metabolite UK-103,320 (UK) was studied by square wave techniques, leading to two methods for its total determination in biological samples (urine and human serum). The application of the square...

Cite
Rodríguez J, Berzas JJ, Castañeda G, et al. Determination of sildenafil citrate (viagra) and its metabolite (UK-103,320) by square-wave and adsorptive stripping square-wave voltammetry. Total determination in biological samples. Talanta. 2004;62(2):427-32doi: 10.1016/j.talanta.2003.07.017.
Rodríguez, J., Berzas, J. J., Castañeda, G., & Rodríguez, N. (2004). Determination of sildenafil citrate (viagra) and its metabolite (UK-103,320) by square-wave and adsorptive stripping square-wave voltammetry. Total determination in biological samples. Talanta, 62(2), 427-32. https://doi.org/10.1016/j.talanta.2003.07.017
Rodríguez, J, et al. "Determination of sildenafil citrate (viagra) and its metabolite (UK-103,320) by square-wave and adsorptive stripping square-wave voltammetry. Total determination in biological samples." Talanta vol. 62,2 (2004): 427-32. doi: https://doi.org/10.1016/j.talanta.2003.07.017
Rodríguez J, Berzas JJ, Castañeda G, Rodríguez N. Determination of sildenafil citrate (viagra) and its metabolite (UK-103,320) by square-wave and adsorptive stripping square-wave voltammetry. Total determination in biological samples. Talanta. 2004 Feb 06;62(2):427-32. doi: 10.1016/j.talanta.2003.07.017. PMID: 18969313.
Copy Download .nbib Format: NLM
Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients.

Indian journal of nephrology

Ghafari A, Farshid B, Afshari AT, Sepehrvand N, Rikhtegar E, Ghasemi K, Hatami S.
PMID: 21072154
Indian J Nephrol. 2010 Jul;20(3):142-5. doi: 10.4103/0971-4065.70845.

Erectile dysfunction (ED) is common among patients with end-stage renal disease (ESRD), who undergo hemodialysis (HD). The aim of this study was to evaluate the safety and effectiveness of sildenafil in male HD patients with ED. Twenty-seven HD patients...

Cite
Ghafari A, Farshid B, Afshari AT, et al. Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients. Indian J Nephrol. 2010;20(3):142-5doi: 10.4103/0971-4065.70845.
Ghafari, A., Farshid, B., Afshari, A. T., Sepehrvand, N., Rikhtegar, E., Ghasemi, K., & Hatami, S. (2010). Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients. Indian journal of nephrology, 20(3), 142-5. https://doi.org/10.4103/0971-4065.70845
Ghafari, A, et al. "Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients." Indian journal of nephrology vol. 20,3 (2010): 142-5. doi: https://doi.org/10.4103/0971-4065.70845
Ghafari A, Farshid B, Afshari AT, Sepehrvand N, Rikhtegar E, Ghasemi K, Hatami S. Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients. Indian J Nephrol. 2010 Jul;20(3):142-5. doi: 10.4103/0971-4065.70845. PMID: 21072154; PMCID: PMC2966980.
Copy Download .nbib Format: NLM
Re: Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.

European urology

Hatzimouratidis K.
PMID: 17373047
Eur Urol. 2007 Jan;51(1):278. doi: 10.1016/j.eururo.2006.09.029.

No abstract available.

Cite
Hatzimouratidis K. Re: Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. Eur Urol. 2007;51(1):278doi: 10.1016/j.eururo.2006.09.029.
Hatzimouratidis, K. (2007). Re: Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. European urology, 51(1), 278. https://doi.org/10.1016/j.eururo.2006.09.029
Hatzimouratidis, Konstantinos. "Re: Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction." European urology vol. 51,1 (2007): 278. doi: https://doi.org/10.1016/j.eururo.2006.09.029
Hatzimouratidis K. Re: Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. Eur Urol. 2007 Jan;51(1):278. doi: 10.1016/j.eururo.2006.09.029. PMID: 17373047.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 164 entries